Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.
Alexander M Sherwood, Thomas E Prisinzano
Expert Review of Clinical Pharmacology December 17, 2017 DOI: 10.1080/17512433.2018.1415755 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Anxiety Depression Ketamine MDMA Psilocybin PTSD |
| Keywords | Humans Hallucinogens Psychotropic drugs Mental disorders Drug design Drug policy Entactogen Psychedelic |
Abstract
Disrupted mental health affects up to one in three individuals globally and is an unmet medical challenge contributing to individual suffering as well as significant societal and economic burden [1...